|
Genomewide Search for Loci Underlying Metabolic Syndrome Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified medical advice, visits or professional assistance with a genuine dr.. We are not doctors. Always consult your mD about Genomewide Search for Loci Underlying Metabolic Syndrome conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Genomewide Search for Loci Underlying Metabolic Syndrome Clinical research trials and Genomewide Search for Loci Underlying Metabolic Syndrome medical trials take place in many of places throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectiveness of new does drugs. The purpose of the studies / projects is to solve specific human healthcare questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to find cures for all varieties of conditions, like Genomewide Search for Loci Underlying Metabolic Syndrome. Genomewide Search for Loci Underlying Metabolic Syndrome Clinical Trials and other clinical trials allow for volunteers to have health treatment options before they are available to the masses. Many times the human subjects acquire professional assistance for free of charge, and sometimes they are compensated for their time. Occasionally there is a cost for a Genomewide Search for Loci Underlying Metabolic Syndrome clinical trial. Test subjects typically obtain the finest healthcare available for their Genomewide Search for Loci Underlying Metabolic Syndrome condition. Dangers are a reality, nevertheless, and might include additional or frequent doctor trips, medical dangers (possibly life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "G" Clinical Trials Conditions > Genomewide Search for Loci Underlying Metabolic Syndrome  Genomewide Search for Loci Underlying Metabolic Syndrome
Genomewide Search for Loci Underlying Metabolic Syndrome
For Condition: Hypertension,Heart Diseases,Metabolic Syndrome X,Obesity,Cardiovascular Diseases,Hyperinsulinism,Insulin Resistance
Status: No longer recruiting
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To identify the genes involved in the metabolic syndrome.
Details: BACKGROUND: Metabolic syndrome, characterized by clustering of multiple metabolic abnormalities including abdominal obesity, dyslipidemia, hyperinsulinemia, hyperglycemia, and hypertension, is one of the most important risk factors for cardiovascular disease and stroke. Genetics play a significant role in determining the individual susceptibility to metabolic syndrome and the inter-individual variation in its associated phenotypes, though these genetic factors remain largely unknown. The long-term goal is to identify the metabolic syndrome susceptibility genes and their functional variants. DESIGN NARRATIVE: The goal of the research is to study the underlying phenotypic structure of the metabolic syndrome and to systematically search for genetic loci predisposing to the metabolic syndrome using the genome scan approach. The specific aims are: (1) to screen about 10,000 sibling pairs aged 40 to 64 years in Anqing, Anhui China, on intermediate phenotypes of the metabolic syndrome including body mass index, waist and hip circumference, serum lipid profiles (triglyceride, HDL-, LDL-, and total cholesterol), fasting serum glucose and insulin level, and blood pressure; (2) to study the underlying phenotypic structure of the metabolic syndrome in the about 10,000 ascertained sibling pairs using factor analysis; (3) to select and genome scan 800 nuclear families from the pool of the ascertained sibling pairs using Weber screening set 10 markers. Each selected nuclear family contains a "proband" and >=3 other family members. The values of the three most significant factors for metabolic syndrome in the factor analysis (see specific aim 2) will be used to classify "proband" status for each subject. A "proband" is defined as having >=2 out of 3 factor values falling into the same side of the 10/90 percentile tails of the corresponding age- and sex-adjusted population distributions; (4) to test for linkage in the genome-scanned families on intermediate phenotypes and factors of metabolic syndrome using the Unified Haseman-Elston method. In addition to the univariate test, linkage analysis will be performed using a novel multivariate version of the Unified H-E method, which has recently been proposed and shown to be significantly more powerful than the univariate test for traits with common genetic determinants; (5) to perform expansion or replication linkage studies on loci identified in the genome scan in 300-400 additional families with >=1 proband with a denser set of markers.
Eligibility:
Study Type: Observational, Natural History, Defined Population
Minimum Age/Maximum Age: 40 Years/64 Years
Genders: Both
Protocol Entry Criteria: No eligibility criteria
Total Enrollment:
Location and Contact Information:
Overall Study Official:
XuXin, , Harvard School of Public Health
Additional Information:
Study ID Numbers: 1241;
Study Start Date: September 2003
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00074451
Other Cardiovascular Diseases Studies:
1. Potential Risk Factors for Stroke
2. Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers
3. Dietary Intervention Study for Hypertension (DISH)
4. Study of Norepinephrine Levels and Sympathetic Nervous System Activity
5. Maturational Changes in Cardiac Structures -- Blood Pressure Relationship -- SCOR in Hypertension
Related Studies:
Other Cardiovascular Diseases Clinical Trials
Other Clinical Trials
Other Clinical Trials
Genomewide Search for Loci Underlying Metabolic Syndrome
|
|
|
|
|
|
|
|
